Aptimmune Biologics

Curated by Signal

Manufacturer of swine vaccines based on advanced mucosal technology

Overview

Manufacturer of swine vaccines based on advanced mucosal technology. The company specializes in the development and application of prophylactic measures against viral diseases of swine. They are developing prophylaxis vaccines against Porcine Reproductive and Respiratory Syndrome (PRRS) virus. It utilizes novel technologies to create effective nasal delivery vaccines against PRRSV such as the proprietary pig alveolar macrophage cell line ZMAC.

Key facts

Founded: 2010
Headquarters: Champaign, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

FitMama
A fitness and nutrition application for women
Health TechnologyBoulder, United States
Headspace
Provider of guided meditation sessions and mindfulness training
Health TechnologySanta Monica, United States
Clarify
Company provides healthcare analytics and value-based payments platform services
Health TechnologySan Francisco, United States

About Aptimmune Biologics

What does Aptimmune Biologics do?

Manufacturer of swine vaccines based on advanced mucosal technology.

Where is Aptimmune Biologics headquartered?

Aptimmune Biologics is headquartered in Champaign, United States.

When was Aptimmune Biologics founded?

Aptimmune Biologics was founded in 2010.

Which sector is Aptimmune Biologics in?

Aptimmune Biologics operates in Health Technology.

Who are Aptimmune Biologics's competitors?

Companies similar to Aptimmune Biologics include FitMama, Headspace, and Clarify.